Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amphotericin B cochleates - BioDelivery Sciences

Drug Profile

Amphotericin B cochleates - BioDelivery Sciences

Alternative Names: BioNasal Amphotericin B; Bioral amphotericin B; Bioral Amphotericin B; Encochleated amphotericin B; SinuNase

Latest Information Update: 11 Sep 2013

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioDelivery Sciences International
  • Developer Accentia Biopharmaceuticals; BioDelivery Sciences International; Drugs for Neglected Diseases Initiative Foundation
  • Class Antifungals; Antiprotozoals; Macrolides
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Chagas disease; Leishmaniasis; Mycoses; Rhinosinusitis; Sinusitis

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 11 Sep 2013 Discontinued - Phase-I for Mycoses in USA (PO)
  • 11 Sep 2013 Discontinued - Phase-III for Rhinosinusitis in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top